A promising strategy for increased intracellular delivery of nucleic acids with the benefit for targeting is photochemical internalization (PCI). PCI relies on the use of a photosensitizing compound that photochemically destroys membranes in the endocytic pathway after illumination, resulting in cytosolic transfer of endosomal content. PCI technology combined with biodegradable polyamino acid carriers and nucleic acids delivers effective targeting and improved biosafety. In an in vitro model system, we have evaluated various poly-l-lysine (PLL), poly-l-histidine (PLH), and poly-l-arginine (PLA) formulations for light-directed small interference RNA (siRNA) gene silencing and messenger RNA (mRNA) delivery. We find that PLA formulations are suitable as siRNA and mRNA carriers in a strictly light-directed manner.
Get full access to this article
View all access options for this article.
References
1.
ALIH.M., URBINATIG., RAOUANEM., MASSAAD-MASSADEL.2012. Significance and applications of nanoparticles in siRNA delivery for cancer therapy. Expert Rev. Clin. Pharmacol., 5:403–412.
BERGK., SELBOP.K., PRASMICKAITEL., TJELLET.E., SANDVIGK., MOANJ., GAUDERNACKG., FODSTADO., KJOLSRUDS., ANHOLTH.et al.1999. Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. Cancer Res., 59:1180–1103.
BOES., LONGVAA.S., HOVIGE.2007. Photochemically induced gene silencing using small interfering RNA molecules in combination with lipid carriers. Oligonucleotides, 17:166–173.
6.
BOES., LONGVAA.S., HOVIGE.2008a. Evaluation of various polyethylenimine formulations for light-controlled gene silencing using small interfering RNA molecules. Oligonucleotides, 18:23–32.
7.
BOES., LONGVAA.S., HOVIGE.2008b. Evaluation of various polyethylenimine formulations for light-controlled gene silencing using small interfering RNA molecules. Oligonucleotides, 18:123–32.
BOES.L., LONGVAA.S., HOVIGE.2010b. Cyclodextrin-containing polymer delivery system for light-directed siRNA gene silencing. Oligonucleotides, 20:175–182.
10.
BOUSSIFO., LEZOUALC'HF., ZANTAM.A., MERGNYM.D., SCHERMAND., DEMENEIXB., BEHRJ.P.1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U. S. A., 92:7297–7301.
11.
CHOIJ.S., NAMK., PARKJ.Y., KIMJ.B., LEEJ.K., PARKJ.S.2004. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. J Control. Release, 99:445–456.
12.
DAVISM.E., ZUCKERMANJ.E., CHOIC.H., SELIGSOND., TOLCHERA., ALABIC.A., YENY., HEIDELJ.D., RIBASA.2010. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature, 464:1067–1070.
13.
DIETZEA., BONSTEDA., HOGSETA., BERGK.2003. Photochemical internalization enhances the cytotoxic effect of the protein toxin gelonin and transgene expression in sarcoma cells. Photochem. Photobiol., 78:283–289.
14.
FISHERK.J., WILSONJ.M.1997. The transmembrane domain of diphtheria toxin improves molecular conjugate gene transfer. Biochem J., 321:49–58.
15.
FODSTADO., BROGGERA., BRULANDO., SOLHEIMO.P., NESLANDJ.M., PIHLA.1986. Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma. Int. J. Cancer, 38:33–40.
GUOJ., CHENGW.P., GUJ., DINGC., QUX., YANGZ., O'DRISCOLLC.2011. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-l-lysine nanocarrier to suppress prostate cancer growth in mice. Eur. J. Pharm. Sci., 45:521–523
18.
HOGSETA., PRASMICKAITEL., TJELLET.E., BERGK.2000. Photochemical transfection: a new technology for light-induced, site-directed gene delivery. Hum. Gene Ther., 11:869–880.
19.
HUANGM., FONGC.W., KHORE., LIML.Y.2005. Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. J. Control. Release, 106:391–406.
JORGENSENJ.A., HOVIGE., BOES.L.2012. Potent gene silencing in vitro at physiological pH using chitosan polymers. Nucleic Acid Ther., 22:96–102.
22.
KIME.J., SHIMG., KIMK., KWONI.C., OHY.K., SHIMC.K.2009. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs. J. Gene Med., 11:791–803.
23.
KIMH.K., DAVAAE., MYUNGC.S., PARKJ.S.2010. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid. Int. J. Pharm., 392:141–147.
24.
KIMT.H., IHMJ.E., CHOIY.J., NAHJ.W., CHOC.S.2003. Efficient gene delivery by urocanic acid-modified chitosan. J. Control. Release, 93:389–402.
25.
KREITERS., DIKENM., SELMIA., TURECIO., SAHINU.2011. Tumor vaccination using messenger RNA: prospects of a future therapy. Curr. Opin. Immunol., 23:399–406.
26.
KULKARNIR.P., MISHRAS., FRASERS.E., DAVISM.E.2005. Single cell kinetics of intracellular, nonviral, nucleic acid delivery vehicle acidification and trafficking. Bioconjug. Chem., 16:986–994.
27.
KYTEJ.A., GAUDERNACKG.2006. Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells. Cancer Immunol. Immunother., 55:1432–1442.
28.
MIDOUXP., KICHLERA., BOUTINV., MAURIZOTJ.C., MONSIGNYM.1998. Membrane permeabilization and efficient gene transfer by a peptide containing several histidines. Bioconjug. Chem., 9:260–267.
29.
MITCHELLD.J., KIMD.T., STEINMANL., FATHMANC.G., ROTHBARDJ.B.2000. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res., 56:318–325.
30.
MORIGUCHIR., KOGUREK., AKITAH., FUTAKIS., MIYAGISHIM., TAIRAK., HARASHIMAH.2005. A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids. Int. J. Pharm., 301:277–285.
31.
OLIVEIRAS., FRETZM.M., HOGSETA., STORMG., SCHIFFELERSR.M.2007. Photochemical internalization enhances silencing of epidermal growth factor receptor through improved endosomal escape of siRNA. Biochim. Biophys. Acta, 1768:1211–1217.
32.
OLIVEIRAS., HOGSETA., STORMG., SCHIFFELERSR.M.2008. Delivery of siRNA to the target cell cytoplasm: photochemical internalization facilitates endosomal escape and improves silencing efficiency, in vitro and in vivo. Curr. Pharm. Des., 14:3686–3697.
33.
OPANASOPITP., TRAGULPAKSEEROJNJ., APIRAKARAMWONGA., NGAWHIRUNPATT., ROJANARATAT., RUKTANONCHAIU.2011. The development of poly-l-arginine-coated liposomes for gene delivery. Int. J. Nanomedicine, 6:2245–2252.
34.
OUYANGD., ZHANGH., PAREKHH.S., SMITHS.C.2011. The effect of pH on PAMAM dendrimer-siRNA complexation: endosomal considerations as determined by molecular dynamics simulation. Biophys Chem, 158:126–133.
35.
RAEMDONCKK., NAEYEB., HOGSETA., DEMEESTERJ., DE SMEDTS.C.2010. Prolonged gene silencing by combining siRNA nanogels and photochemical internalization. J. Control. Release, 145:281–288.
36.
SAEBOE-LARSSENS., FOSSBERGE., GAUDERNACKG.2002. mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT)J. Immunol. Methods, 259:191–203.
37.
SELBOP.K., WEYERGANGA., HOGSETA., NORUMO.J., BERSTADM.B., VIKDALM., BERGK.2010. Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules. J. Control. Release, 148:2–12.
38.
SWAMIA., AGGARWALA., PATHAKA., PATNAIKS., KUMARP., SINGHY., GUPTAK.C.2007. Imidazolyl-PEI modified nanoparticles for enhanced gene delivery. Int. J. Pharm., 335:180–192.
39.
VANDESOMPELEJ., DE PRETERK., PATTYNF., POPPEB., VAN ROYN., DE PAEPEA., SPELEMANF.2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol., 3:1–11.
40.
VARKOUHIA.K., LAMMERST., SCHIFFELERSR.M., VAN STEENBERGENM.J., HENNINKW.E., STORMG.2011. Gene silencing activity of siRNA polyplexes based on biodegradable polymers. Eur. J. Pharm. Biopharm., 77:450–457.
41.
WOOJ.G., KIMN.Y., YANGJ.M., SHINS.2011. Biodistribution and blood clearance of plasmid DNA administered in arginine peptide complexes. Genet. Vaccines Ther., 9:13.
42.
WUG.Y., WUC.H.1988. Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro. Biochemistry, 27:887–892.
43.
ZHANGH., FENGH., LUOL., ZHOUQ., LUOZ., PENGY.2010. Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2. Virus Res., 150:22–27.
